Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Standard Assays for the Study of Autophagy in the Ex Vivo Retina

  • Gómez-Sintes, Raquel
  • Villarejo-Zori, Beatriz
  • Serrano-Puebla, Ana
  • Esteban-Martínez, Lorena
  • Sierra-Filardi, Elena
  • Ramírez-Pardo, Ignacio
  • Rodríguez-Muela, N.
  • Boya, Patricia
Autophagy is a catabolic pathway that mediates the degradation and recycling of intracellular components, and is a key player in a variety of physiological processes in cells and tissues. Recent studies of autophagy in the eye suggest that this pathway is fundamental for the preservation of retinal homeostasis. Given its accessible location outside the brain, the retina is an ideal organ in which to study the central nervous system and a wide range of neuronal processes, from development to neurodegeneration. Here we review several methods used to assess autophagy in the retina in both physiological and pathological conditions., Research in the Boya Lab is supported by grants BFU2015-65623 (FEDER supported) and BFU2015-71869-REDT from Spain’s Ministerio de Economía y Competitividad (MINECO), COST Action Transautophagy (CA15138), and ITN H2020-MSCA-ITN-2017 DRIVE. BVZ is a recipient of a Ph.D. contract from the Fundación Tatiana Pérez de Guzmán el Bueno, and ASP has an FPI contract from MINECO. NRM and RGS have a Juan de la Cierva contract supported by MINECO., We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Autophagy in stem cells: repair, remodelling and metabolic reprogramming

  • Boya, Patricia
  • Codogno, Patrice
  • Rodríguez-Muela, N.
14 p.-6 fig., Autophagy is a catabolic pathway by which cellular components are delivered to the lysosome for degradation and recycling. Autophagy serves as a crucial intracellular quality control and repair mechanism but is also involved in cell remodelling during development and cell differentiation. In addition, mitophagy, the process by which damaged mitochondria undergo autophagy, has emerged as key regulator of cell metabolism. In recent years, a number of studies have revealed roles for autophagy and mitophagy in the regulation of stem cells, which represent the origin for all tissues during embryonic and postnatal development, and contribute to tissue homeostasis and repair throughout adult life. Here, we review these studies, focussing on the latest evidence that supports the quality control, remodelling and metabolic functions of autophagy during the activation, self-renewal and differentiation of embryonic, adult and cancer stem cells., P.B. is supported by Spain's Ministerio de Economía y Competitividad [BFU2015-65623 (FEDER funding) and BFU2015-71869-REDT], European Cooperation in Science and Technology (COST) Action Transautophagy (CA15138) and the European Union Horizon 2020 Marie Skłodowska-Curie Innovative Training Networks (ITN-ETN) under grant agreement 765912. N.R.-M. is supported by a grant from the Muscular Dystrophy Association (MDA376743) and a Juan de la Cierva Incorporación fellowship from Spain's Ministerio de Economía y Competitividad. P.C. is supported by funding from the Institut National de la Santé et de la Recherche Médicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), and Université Paris Descartes-Sorbonne Paris Cité and grants from the Institut National Du Cancer (INCa) and the Agence Nationale de la Recherche (ANR)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Lysosome-dependent cell death and deregulated autophagy induced by amine-modified polystyrene nanoparticles

  • Wang, Fengjuan
  • Salvati, Anna
  • Boya, Patricia
13 p.-5 fig., Nanoparticles (NPs) typically accumulate in lysosomes. However, their impact on lysosomal function, as well as autophagy, a lysosomal degradative pathway, is still not well known. We have previously reported in the 1321N1 cell line that amine-modified polystyrene (NH2-PS) NPs induce apoptosis through damage initiated in the lysosomes leading ultimately to release of lysosomal content in the cytosol, followed by apoptosis. Here, by using a combination of biochemical and cell biological approaches, we have characterized in a mouse embryonic fibroblast cell line that the lysosomal alterations induced by NH2-PS NPs is progressive, initiating from mild lysosomal membrane permeabilization (LMP), to expansion of lysosomal volume and intensive LMP before the summit of cell death. Though the cells initially seem to induce autophagy as a surviving mechanism, the damage of NH2-PS NPs to lysosomes probably results in lysosomal dysfunctions, leading to blockage of autophagic flux at the level of lysosomes and the eventual cell death., This work was conducted under the INSPIRE Programme of the Irish Government's PRTL4, National Development Plan 2007–2013 (F.W. and A.S.), BFU2015-65623 and FEDER (P.B.). Additionally, it was supported by the ESF Research Networking Programme EpitopeMap (F.W.). F.W. was a recipient of a post-doctoral fellowship from the University of Strasbourg Institute for Advanced Study (USIAS). Finally, we acknowledge the support of the TRANSAUTOPHAGY COST Action, CA15138., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mitophagy, metabolism, and cell fate

  • Esteban-Martínez, Lorena
  • Sierra-Filardi, Elena
  • Boya, Patricia
7 p.-1 fig., Mitophagy is the process by which cells eliminate damaged or superfluous mitochondria by degrading them within lysosomes. We show that during development, selective removal of mitochondria by autophagy induces a metabolic shift toward glycolysis that is essential for differentiation of several cell types. These findings suggest potential applications of cell-fate manipulation strategies targeting mitophagy., Research in the P.B. lab is supported by grants BFU2015-65623 and BFU2015-71869-REDT from Spain’s Ministerio de Economía y Competitividad, COST Action Transautophagy (CA15138), and ITN MSCA-ITN-ETN 765912., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Driving next-generation autophagy researchers towards translation (DRIVE), an international PhD training program on autophagy

  • Kraft, Claudine
  • Boya, Patricia
  • Codogno, Patrice
  • Elazar, Zvulun
  • Eskelinen, Eeva-Liisa
  • Farrés, Judith
  • Kirkin, Vladimir
  • Jungbluth, Heinz
  • Martínez Gil, Ana
  • Pless, Ole
  • Primard, Charlotte
  • Proikas-Cezanne, Tassula
  • Simonsen, Anne
  • Reggiori, Fulvio
.DRIVE is supported by a MarieSkłodowska-Curie ETN grant under theEuropean Union’s Horizon 2020 Research and Innovation Programme(Grant Agreement No 765912). P.B. is also supported by the Ministerio de Ciencia, Innovación y Universidades (BFU2015-65623) and by Redes de laComunidad de Madrid 2017/BMD-3813. Work in P.C. laboratory is sup-ported by institutional fundings from INSERM, CNRS and University ParisDescartes and by grants from Agence Nationale pour la Recherche (ANR) andFondation pour la Recherche Médicale(FRM). Z.E. research is supported bythe Israel Science Foundation ISF, the Legacy Heritage Fund and theWeizmann Institute Minerva center. E.-L.E. is also supported by TheAcademy of Finland project grant (286787), by Magnus EhrnroothFoundation, and by COST Action 15138 Transautophagy. V.K. is also sup-ported by the CRUK programme grant C2739/A22897. C.K. is also supportedby funding from the Vienna Science and Technology Fund (WWTF, VRG10-001) from the FWF Austrian Science Fund (P28113-B28), from the EuropeanResearch Council (ERC) under the European Union’s Horizon 2020 Researchand Innovation Programme (grant agreement No 769065), and from theEMBO Young Investigator Program. H.J. is supported by a grant fromAction Medical Research (Grant reference GN 2446), United Kingdom. O.P.is also supported by the German Federal Ministry of Education and Research(BMBF) (01EK1608B and 13GW0128B). T.P.-C. is also supported by theGerman Research Foundation (Deutsche Forschungsgemeinschaft, DFG);SFB/TRR 209 (project B02); FOR 2625 (project 1). A.S. is also supported bythe Research Council of Norway (project # 221831 and through its Centres ofExcellence funding scheme project # 262652) and the Norwegian CancerSociety (project #190251). F.R. is also supported by ZonMW VICI(016.130.606), ZonMW TOP (91217002), ALW Open Programme(ALWOP.310) and Marie Skłodowska-Curie Cofund (713660) grant, DRIVEis supported by a MarieSkłodowska-Curie ETN grant under the European Union’s Horizon 2020 Research and Innovation Programme(Grant Agreement No 765912). P.B. is also supported by the Ministerio deCiencia, Innovación y Universidades (BFU2015-65623) and by Redes de la Comunidad de Madrid 2017/BMD-3813. Work in P.C. laboratory is sup-ported by institutional fundings from INSERM, CNRS and University ParisDescartes and by grants from Agence Nationale pour la Recherche (ANR) andFondation pour la Recherche Médicale(FRM). Z.E. research is supported bythe Israel Science Foundation ISF, the Legacy Heritage Fund and theWeizmann Institute Minerva center. E.-L.E. is also supported by The Academy of Finland project grant (286787), by Magnus EhrnroothFoundation, and by COST Action 15138 Transautophagy. V.K. is also sup-ported by the CRUK programme grant C2739/A22897. C.K. is also supportedby funding from the Vienna Science and Technology Fund (WWTF, VRG10-001) from the FWF Austrian Science Fund (P28113-B28), from the EuropeanResearch Council (ERC) under the European Union’s Horizon 2020 Researchand Innovation Programme (grant agreement No 769065), and from the EMBO Young Investigator Program. H.J. is supported by a grant fromAction Medical Research (Grant reference GN 2446), United Kingdom. O.P.is also supported by the German Federal Ministry of Education and Research(BMBF) (01EK1608B and 13GW0128B). T.P.-C. is also supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG);SFB/TRR 209 (project B02); FOR 2625 (project 1). A.S. is also supported by the Research Council of Norway (project # 221831 and through its Centres ofExcellence funding scheme project # 262652) and the Norwegian CancerSociety (project #190251). F.R. is also supported by ZonMW VICI(016.130.606), ZonMW TOP (91217002), ALW Open Programme(ALWOP.310) and Marie Skłodowska-Curie Cofund (713660) grants., Peer reviewed